X-Biotix Therapeutics

X-Biotix Therapeutics, Inc. is a biotechnology company specializing in the development of novel small molecule antibiotic scaffolds for multi-drug resistant (MDR) Gram-negative pathogens to address the urgent and growing global threat of antibiotic resistance. The company is applying a multi-target strategy to generate a pipeline of effective antibiotics with inhibitory activity against a wide range of biological targets in essential pathways of Gram-negative bacterial cells and which are also predicted to defeat known antibiotic resistance mechanisms.